90 related articles for article (PubMed ID: 2657866)
1. Pharmacokinetics of 3H-cicaprost in healthy volunteers.
Hildebrand M; Staks T; Schütt A; Matthes H
Prostaglandins; 1989 Feb; 37(2):259-73. PubMed ID: 2657866
[TBL] [Abstract][Full Text] [Related]
2. Studies on the pharmacokinetics of ZK 96 480, a novel PGI2-mimetic, in rat and cynomolgus monkey.
Hildebrand M
Prostaglandins; 1986 Sep; 32(3):425-38. PubMed ID: 3538205
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of iloprost and cicaprost in mice.
Hildebrand M
Prostaglandins; 1992 Nov; 44(5):431-42. PubMed ID: 1281921
[TBL] [Abstract][Full Text] [Related]
4. Bioactivation of eptaloprost in animals and man.
Hildebrand M
Prostaglandins; 1993 Aug; 46(2):177-89. PubMed ID: 7692471
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 micrograms.
Hildebrand M; Staks T; Nieuweboer B
Eur J Clin Pharmacol; 1990; 39(2):149-53. PubMed ID: 2253664
[TBL] [Abstract][Full Text] [Related]
6. The prostacyclin analogue cicaprost inhibits metastasis of tumours of R 3327 MAT Lu prostate carcinoma and SMT 2A mammary carcinoma.
Schirner M; Schneider MR
J Cancer Res Clin Oncol; 1992; 118(7):497-501. PubMed ID: 1624541
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a sensitive and specific radioimmunoassay for the determination of cicaprost in biological samples.
Hildebrand M; Nieuweboer B; Schütt A
J Immunoassay; 1994 May; 15(2):171-90. PubMed ID: 8040351
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374, in the beagle dog.
Krause W
Prostaglandins Leukot Med; 1984 Feb; 13(2):143-51. PubMed ID: 6201926
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of radio-labeled iloprost in elderly volunteers.
Krause W; Krais T
Eur J Clin Pharmacol; 1987; 32(6):597-605. PubMed ID: 2443364
[TBL] [Abstract][Full Text] [Related]
10. Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.
Belch JJ; McLaren M; Lau CS; Mackay IR; Bancroft A; McEwen J; Thompson JM
Br J Clin Pharmacol; 1993 Jun; 35(6):643-7. PubMed ID: 8329292
[TBL] [Abstract][Full Text] [Related]
11. Inter-species extrapolation of pharmacokinetic data of three prostacyclin-mimetics.
Hildebrand M
Prostaglandins; 1994 Nov; 48(5):297-312. PubMed ID: 7531864
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tolerability of oral iloprost in thromboangiitis obliterans patients.
Hildebrand M
Eur J Clin Pharmacol; 1997; 53(1):51-6. PubMed ID: 9349930
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intravenous ataprost alfadex, a new prostaglandin I2 analog in healthy volunteers.
Uematsu T; Umemura K; Nakano M; Kosuge K; Nakashima M
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):373-5. PubMed ID: 8225681
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of pirazolac--a new anti-inflammatory drug--in human volunteers. I. Absorption, disposition, biotransformation and excretion.
Täuber U; Weiss C; Krause W; Acksteiner B; Matthes H
Eur J Drug Metab Pharmacokinet; 1985; 10(1):41-53. PubMed ID: 4029220
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techique.
Heikkinen H; Saraheimo M; Antila S; Ottoila P; Pentikäinen PJ
Eur J Clin Pharmacol; 2001; 56(11):821-6. PubMed ID: 11294372
[TBL] [Abstract][Full Text] [Related]
16. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
[TBL] [Abstract][Full Text] [Related]
17. A randomised, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis.
Lau CS; Belch JJ; Madhok R; Cappell H; Herrick A; Jayson M; Thompson JM
Clin Exp Rheumatol; 1993; 11(1):35-40. PubMed ID: 8453795
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.
Marzolini C; Decosterd LA; Shen F; Gander M; Leyvraz S; Bauer J; Buclin T; Biollaz J; Lejeune F
Cancer Chemother Pharmacol; 1998; 42(6):433-40. PubMed ID: 9788568
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and disposition of terodiline in man.
Hallén B; Karlsson MO; Stromberg S; Norén B
J Pharm Sci; 1994 Sep; 83(9):1241-6. PubMed ID: 7830238
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374, in the monkey (Macaca fascicularis).
Krause W; Schubert M; Totzek M
Prostaglandins Leukot Med; 1983 Jul; 11(3):325-38. PubMed ID: 6193537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
